NasdaqCM - Nasdaq Real Time Price USD

Viemed Healthcare, Inc. (VMD)

Compare
8.55 -0.33 (-3.72%)
At close: October 31 at 4:00 PM EDT
Loading Chart for VMD
DELL
  • Previous Close 8.88
  • Open 8.88
  • Bid 8.54 x 100
  • Ask 8.58 x 100
  • Day's Range 8.55 - 8.88
  • 52 Week Range 6.21 - 10.44
  • Volume 162,115
  • Avg. Volume 127,089
  • Market Cap (intraday) 331.961M
  • Beta (5Y Monthly) 1.47
  • PE Ratio (TTM) 37.17
  • EPS (TTM) 0.23
  • Earnings Date Nov 6, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 12.27

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.

www.viemed.com

1,121

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VMD

View More

Performance Overview: VMD

Trailing total returns as of 10/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

VMD
8.92%
S&P 500
19.62%

1-Year Return

VMD
37.24%
S&P 500
36.93%

3-Year Return

VMD
49.21%
S&P 500
23.89%

5-Year Return

VMD
4.40%
S&P 500
87.26%

Compare To: VMD

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VMD

View More

Valuation Measures

Annual
As of 10/31/2024
  • Market Cap

    331.96M

  • Enterprise Value

    335.62M

  • Trailing P/E

    37.17

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.68

  • Price/Book (mrq)

    2.78

  • Enterprise Value/Revenue

    1.63

  • Enterprise Value/EBITDA

    8.42

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.60%

  • Return on Assets (ttm)

    6.79%

  • Return on Equity (ttm)

    8.40%

  • Revenue (ttm)

    205.7M

  • Net Income Avi to Common (ttm)

    9.47M

  • Diluted EPS (ttm)

    0.23

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.81M

  • Total Debt/Equity (mrq)

    10.29%

  • Levered Free Cash Flow (ttm)

    3.09M

Research Analysis: VMD

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 54.97M
Earnings 1.47M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

9.30
12.27 Average
8.55 Current
15.00 High
 

Company Insights: VMD